US5474783A
(en)
*
|
1988-03-04 |
1995-12-12 |
Noven Pharmaceuticals, Inc. |
Solubility parameter based drug delivery system and method for altering drug saturation concentration
|
US5633000A
(en)
*
|
1994-06-23 |
1997-05-27 |
Axxia Technologies |
Subcutaneous implant
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
ES2227707T3
(es)
*
|
1996-07-15 |
2005-04-01 |
Alza Corporation |
Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina.
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
JP2001503062A
(ja)
*
|
1996-10-30 |
2001-03-06 |
セラテック・インコーポレーテッド |
透過促進剤としての乳酸の脂肪酸エステルの塩
|
US5980898A
(en)
*
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
DE19706824C1
(de)
*
|
1997-02-21 |
1998-03-26 |
Lohmann Therapie Syst Lts |
Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
EP1030668A4
(de)
*
|
1997-11-10 |
2002-09-25 |
Cellegy Pharma Inc |
Penetrationsförderndes und reizminderndes system
|
TW492882B
(en)
*
|
1997-11-28 |
2002-07-01 |
Caleb Pharmaceuticals Inc |
Cholinergic antagonist plaster composition
|
US6210705B1
(en)
*
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
EP1459741A1
(de)
*
|
1997-12-15 |
2004-09-22 |
Noven Pharmaceuticals, Inc. |
Arzneimittel und Verfahren zur Behandlung von Aufmerksamkeitsstörungen und Aufmerksamkeits-/hyperaktivitätsstörungen mit Methylphenidat
|
US6727401B1
(en)
*
|
1998-02-12 |
2004-04-27 |
Watson Pharmaceuticals, Inc. |
Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
|
DE29823343U1
(de)
*
|
1998-03-20 |
1999-07-15 |
Sanol Arznei Schwarz Gmbh |
Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
US6475514B1
(en)
|
1998-12-03 |
2002-11-05 |
Andrew Blitzer |
Athletic patch
|
KR100383252B1
(ko)
*
|
1998-12-17 |
2003-07-16 |
주식회사 삼양사 |
부프레놀핀을함유하는경피투여조성물및이를포함하는패취
|
WO2000064434A1
(fr)
*
|
1999-04-26 |
2000-11-02 |
Lead Chemical Co., Ltd. |
Preparations percutanees contenant de l'oxybutynine
|
AU6403600A
(en)
*
|
1999-06-10 |
2001-01-02 |
Sepracor, Inc. |
Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin
|
AU769079B2
(en)
|
1999-06-25 |
2004-01-15 |
Durham Pharmaceuticals Ltd. |
Topical formulations comprising skin penetration agents and the use thereof
|
GB9918735D0
(en)
*
|
1999-08-09 |
1999-10-13 |
Straken Limited |
Transdermal patches
|
US20010049546A1
(en)
*
|
2000-02-08 |
2001-12-06 |
Israel Dvoretzky |
Multi-purpose drug and heat therapy treatment system
|
US6436428B1
(en)
|
2000-03-21 |
2002-08-20 |
Enhance Pharmaceuticals, Inc. |
Device and method for treating urinary incontinence in females
|
MXPA02010542A
(es)
*
|
2000-04-26 |
2003-10-14 |
Watson Pharmaceuticals Inc |
Minimizacion de experiencias adversas asociadas con la terapia con oxibutinina.
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
EP1307232B1
(de)
*
|
2000-08-03 |
2007-03-07 |
Antares Pharma IPL AG |
Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
DE10060550C1
(de)
*
|
2000-12-06 |
2002-04-18 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
|
US6585963B1
(en)
*
|
2001-02-15 |
2003-07-01 |
Watson Pharmaceuticals, Inc. |
Nail compositions and methods of administering same
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
EP1390383B1
(de)
*
|
2001-05-11 |
2012-02-29 |
Isis Pharmaceuticals, Inc. |
Antisense-permeationsverstärker
|
US6913760B2
(en)
*
|
2001-08-06 |
2005-07-05 |
New England Medical Hospitals, Inc. |
Drug delivery composition
|
AU2002340120A1
(en)
*
|
2001-10-04 |
2003-04-14 |
Cellegy Pharmaceuticals, Inc. |
Semisolid topical hormonal compositions and methods for treatment
|
US7921999B1
(en)
|
2001-12-20 |
2011-04-12 |
Watson Laboratories, Inc. |
Peelable pouch for transdermal patch and method for packaging
|
JP4295467B2
(ja)
*
|
2002-04-12 |
2009-07-15 |
日東電工株式会社 |
貼付剤およびその製造方法
|
KR100469995B1
(ko)
*
|
2002-05-20 |
2005-02-05 |
안국약품 주식회사 |
천식치료제를 함유한 매트릭스형 패취
|
JP4323138B2
(ja)
*
|
2002-06-05 |
2009-09-02 |
日東電工株式会社 |
経皮吸収型製剤およびその製造方法
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
EP1386604A1
(de)
*
|
2002-07-30 |
2004-02-04 |
Schwarz Pharma Ag |
Verbessertes transdermales Verabreichungssystem
|
AU2003268361A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Watson Pharmaceuticals, Inc. |
Drug delivery system for treating urinary incontinence
|
DE10251256A1
(de)
*
|
2002-11-04 |
2004-05-13 |
Novosis Ag |
Transdermales Wirkstoffabgabesystem für Oxybutynin
|
ATE295726T1
(de)
*
|
2002-12-02 |
2005-06-15 |
Sanol Arznei Schwarz Gmbh |
Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
|
DE10261696A1
(de)
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
ATE461681T1
(de)
*
|
2003-04-29 |
2010-04-15 |
Gen Hospital Corp |
Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
|
DE10338174A1
(de)
*
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
MXPA06003316A
(es)
*
|
2003-10-10 |
2006-06-08 |
Antares Pharma Ipl Ag |
Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
EP1611882B1
(de)
*
|
2004-06-01 |
2010-04-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhäsive Pflaster
|
CA2580329C
(en)
|
2004-09-13 |
2015-01-06 |
Chrono Therapeutics Inc. |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
ATE471146T1
(de)
|
2004-10-21 |
2010-07-15 |
Durect Corp |
Transdermale verabreichungssysteme
|
US20070053965A1
(en)
*
|
2005-02-25 |
2007-03-08 |
Gruenenthal Gmbh |
Kit comprising a plaster, optionally containing an active substance, and an agent that at least partially reduces skin irritation
|
WO2006127905A2
(en)
|
2005-05-24 |
2006-11-30 |
Chrono Therapeutics, Inc. |
Portable drug delivery device
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
US10137135B2
(en)
*
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
JP5037831B2
(ja)
*
|
2006-02-15 |
2012-10-03 |
久光製薬株式会社 |
凝集力向上及び徐放化の外用貼付剤
|
US8715723B2
(en)
*
|
2006-02-27 |
2014-05-06 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
WO2007143674A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Verus Pharmaceuticals, Inc. |
Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
|
US20070293582A1
(en)
*
|
2006-06-05 |
2007-12-20 |
Malcolm Hill |
Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
ATE482703T1
(de)
*
|
2006-12-28 |
2010-10-15 |
Kaken Pharma Co Ltd |
Gelzusammensetzung zur behandlung von mykose
|
NZ552816A
(en)
*
|
2007-01-24 |
2009-05-31 |
Bomac Research Ltd |
Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
|
KR101612901B1
(ko)
|
2007-03-02 |
2016-04-15 |
테이카 세이야쿠 가부시키가이샤 |
경피흡수 의약조성물, 의약조성물 저장유닛 및 이것을 이용하는 경피흡수제제
|
US20080226698A1
(en)
|
2007-03-16 |
2008-09-18 |
Mylan Technologies, Inc. |
Amorphous drug transdermal systems, manufacturing methods, and stabilization
|
US10183001B1
(en)
*
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
WO2009018356A1
(en)
*
|
2007-07-30 |
2009-02-05 |
Medacure International, Inc. |
Immune system modulator formulation
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
AU2008336605B2
(en)
*
|
2007-12-12 |
2013-06-27 |
Teikoku Seiyaku Co., Ltd. |
Loxoprofen-containing aqueous plaster
|
US20090297591A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Orient Pharma Co., Ltd. |
Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
|
US8404255B2
(en)
*
|
2008-07-29 |
2013-03-26 |
Matt Gibson |
System and method for transdermal drug delivery
|
JP5472756B2
(ja)
|
2008-10-02 |
2014-04-16 |
マイラン・インク |
多層接着ラミネートの作製方法
|
JP5155128B2
(ja)
*
|
2008-12-11 |
2013-02-27 |
日東電工株式会社 |
メチルフェニデート貼付製剤
|
US8920392B2
(en)
|
2009-05-05 |
2014-12-30 |
Watson Laboratories, Inc. |
Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
|
US8840922B2
(en)
*
|
2009-10-21 |
2014-09-23 |
Teikoku Seiyaku Co., Ltd. |
Transdermally absorbable donepezil-containing preparation
|
KR101738200B1
(ko)
|
2009-12-15 |
2017-05-19 |
데이고꾸세이약꾸가부시끼가이샤 |
염기성 소염 진통제 함유 경피 흡수 제제
|
CA2796575C
(en)
|
2010-04-13 |
2018-05-15 |
Relmada Therapeutics, Inc. |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
EP2563123B1
(de)
|
2010-04-30 |
2018-04-25 |
Merck Sharp & Dohme Corp. |
Neue beta-3-adrenerge rezeptoragonisten
|
FR2972923B1
(fr)
*
|
2011-03-25 |
2013-08-23 |
Urgo Lab |
Composition filmogene contenant un filtre solaire, son utilisation pour le traitement des cicatrices
|
US11786455B2
(en)
|
2011-05-10 |
2023-10-17 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
US9283174B2
(en)
|
2011-05-10 |
2016-03-15 |
Tatsuya Mori |
Non-aqueous patch
|
US9925264B2
(en)
|
2011-05-10 |
2018-03-27 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
JP2014517046A
(ja)
*
|
2011-06-24 |
2014-07-17 |
アセンダ ファーマ インコーポレイテッド |
エステルプロドラッグの吸収を改善するための方法及び改善された医薬組成物
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
HUE039266T2
(hu)
|
2011-09-27 |
2018-12-28 |
Itochu Chemical Frontier Corp |
Nem-vizes tapasz
|
EP2772252B1
(de)
*
|
2011-10-26 |
2020-03-18 |
Hisamitsu Pharmaceutical Co., Inc. |
Oxybutin-haltiges präparat zur transdermalen absorption
|
US20130266643A1
(en)
*
|
2012-04-10 |
2013-10-10 |
Hpo Life Sciences, Inc. |
Compositions comprising glyceryl-triacetate (GTA) and uses in human performance optimization and thermogenesis
|
ES2706994T3
(es)
*
|
2012-09-03 |
2019-04-02 |
Daiichi Sankyo Co Ltd |
Composición farmacéutica de liberación prolongada de administración oral que contiene clorhidrato de hidromorfona
|
SG10202011046RA
(en)
|
2012-09-21 |
2020-12-30 |
Intensity Therapeutics Inc |
Method of treating cancer
|
US9072682B2
(en)
|
2012-12-31 |
2015-07-07 |
Mylan Inc. |
Transdermal dosage form for low-melting point active agent
|
CN103919754B
(zh)
*
|
2013-01-15 |
2018-11-06 |
江苏康倍得药业股份有限公司 |
奥昔布宁药物组合物及其应用
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
US20140271792A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Noven Pharmaceuticals, Inc. |
Methylphenidate transdermal compositions with rubber-based adhesives
|
WO2015139847A1
(en)
*
|
2014-03-21 |
2015-09-24 |
Chironwells Gmbh |
6-(amino acid)-morphinan derivatives in combination with permeation enhancers for use as an orally, rectally, transdermally or nasally administered medicament
|
EP4122460A1
(de)
|
2015-01-09 |
2023-01-25 |
Chase Pharmaceuticals Corporation |
Transdermale oxybutynintherapiesystemkombination
|
US10213586B2
(en)
|
2015-01-28 |
2019-02-26 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
US11285306B2
(en)
|
2017-01-06 |
2022-03-29 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
JP2019034905A
(ja)
*
|
2017-08-17 |
2019-03-07 |
コスメディ製薬株式会社 |
デヒドロ酢酸含有経皮吸収製剤
|
WO2019089523A1
(en)
*
|
2017-10-30 |
2019-05-09 |
Theracaine Llc |
Hydrophobic acid addition salts and pharmaceutical formulations thereof
|
KR101975677B1
(ko)
|
2017-11-20 |
2019-05-07 |
양진석 |
환편기용 보풀 제거장치
|
JP7420797B2
(ja)
|
2018-05-29 |
2024-01-23 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
薬剤送達の方法及びシステム
|
KR102320656B1
(ko)
|
2018-10-26 |
2021-11-02 |
경상국립대학교 산학협력단 |
아세틴 화합물의 생물학적 제조 방법
|
CN113384558A
(zh)
*
|
2021-02-01 |
2021-09-14 |
深圳普洛美康材料有限公司 |
一种递送大麻活性物质的透皮贴剂
|
JP2022122784A
(ja)
|
2021-02-10 |
2022-08-23 |
コスメディ製薬株式会社 |
酸化防止剤含有経皮吸収製剤
|
KR20230026232A
(ko)
|
2021-08-17 |
2023-02-24 |
신신제약 주식회사 |
옥시부티닌을 함유하는 경피흡수제제
|
CN113749968A
(zh)
*
|
2021-10-26 |
2021-12-07 |
奥易生物科技(杭州)有限公司 |
一种快速透皮吸收的化妆品及其制备方法
|